Chemical Exposures: Prostate Cancer and Early BPA Exposure by Josephson, Julian
The role of biology today, like the role of every other science, is simply to describe, and when 
it explains it does not mean that it arrives at finality; it only means that some descriptions are so
charged with significance that they expose the relationship of cause and effect. 
Donald Culross Peattie (1898–1964)
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Prostate Cancer
and Early BPA
Exposure
In animal models, estrogens can drive car-
cinogenesis of the prostate and have long
been suspected of playing a role in human
prostate cancer. Scientists have hypothe-
sized that prenatal exposure to estrogen-
like compounds, including monomeric
bisphenol A (BPA), may account for
recent increases in rates of prostate cancer.
Now a rat study by Gail Prins of the
University of Illinois at Chicago Depart-
ment of Urology, Shuk-Mei Ho of the
University of Cincinnati Department of
Environmental Health, and their col-
leagues provides the first evidence of a
direct link between low-dose BPA expo-
sure during development and later
prostate cancer.
BPA initially was synthesized for use in
estrogenic-type drugs. BPA
also is used as a cross-
linking compound in
the manufacture of
polycarbonate plastics
and epoxy resins. It
leaches from food and
beverage containers and
from dental sealants,
although the latter cur-
rently are not thought to
be a major source of
exposure. Today, this hor-
monally active chemical
is widespread in the envi-
ronment, with detectable
serum levels present in
approximately 90% of
humans in the United States and
other industrialized countries, by
Prins’s estimate. BPA concentrations
measured in placental and fetal tis-
sues may be fivefold higher than
maternal serum levels, with higher
levels found in male fetuses com-
pared to females, according to Prins. 
BPA has been in use for about
50 years in the industrialized world.
Some investigators have proposed
that widespread ingestion of mono-
meric BPA from polycarbonate food
and drink containers might partially
explain recent increases in prostate
cancer rates. According to the American
Cancer Society, rates have been on the rise
since 1975. With the 1987 introduction
of prostate-specific antigen testing, the
newly enhanced ability to diagnose the
disease caused incidence to spike to 240
age-adjusted cases per 100,000 men by
1992. After this “catch-up” period, rates
dropped for three years, but are now back
on the rise.  
In the study, described in the 1 June
2006 issue of Cancer Research, groups of
newborn rats were given high or low doses
of estradiol or an environmentally relevant
dose of BPA. The findings provide a
molecular underpinning for potential
long-term effects by showing changes in
methyl groups on DNA that are responsi-
ble for turning genes on or off. For exam-
ple, one key prostate gene that normally
fuels cell growth during development
stayed turned on in the prostates of male
rats exposed to BPA or elevated estradiol
from birth, says Prins. Such epigenetic
alterations may leave a permanent impres-
sion on genes,
possibly sensitizing the animal to develop-
ing diseases later in life.
One must exercise caution, however,
in extrapolating the current rat findings to
humans. How might one conduct an anal-
ogous program of research on men? The
researchers consider such a program virtu-
ally impossible because 50 years or more
typically would be required for results of
early exposure to BPA to show up as
prostate cancer. 
Indeed, Rebecca Sokol, a professor of
medicine at the University of Southern
California, cautions against extrapolating
human effects from rat studies. She does,
however, note that unlike strong carcino-
gens that damage DNA profoundly, BPA
appears to cause subtle changes that may
pass from one generation to the next. She
asks whether something is happening to
alter genes seemingly without changing
the genetic code itself.
Says Prins, “Our evidence shows that
in an animal model, some genes are
altered by the addition or removal of
methyl groups on the DNA, which
changes the ability of those genes to be
transcribed and translated to proteins. It
is possible that these effects may pass
through generations as has been shown
recently for sperm cells.” However, she
adds, that analysis awaits future studies.
–Julian Josephson
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Disease through the ages. New rat data link BPA exposure during critical periods of early development
to later prostate cancer, raising compelling questions for research in humans.
CHEMICAL EXPOSURESWHO/ILSI Affiliation
Sustained
The International Life Sciences Institute
(ILSI) is set to be honored for its Physical
Activity and Nutrition program as part of
the September 2006 National Congress on
Accelerating Improvement in Childhood
Obesity in Washington, DC. The program
is being singled out for its innovative
approaches to educating children, parents,
and caregivers about managing child obesi-
ty. However, such praise contrasts sharply
with criticism that was leveled at ILSI just
months ago. 
At a 27 January 2006 meeting in
Geneva, the WHO Executive Board
reviewed ILSI’s NGO status, along with
that of several other NGOs, as part of the
WHO’s standard three-year review cycle.
The National Resources Defense Council,
an environmental action group, was calling
for the WHO to sever its relationship with
ILSI, based on the fact that ILSI’s member-
ship includes representatives of major multi-
national corporations with a vested interest
in public health matters. 
The board ultimately decided to main-
tain official relations with ILSI, describing
its role as “a knowledge resource base for the
application of leading-edge science and
knowledge transfer in the fields of food and
chemical safety.” ILSI is therefore still per-
mitted to attend WHO governing body
meetings and make statements at these
meetings. Although this presence does not
come with voting privileges, it affords such
an organization valuable “insider” status.
However, this latest decision by the Exec-
utive Board does exclude any collaboration
by ILSI on normative activities, defined as
“setting microbiological or chemical stan-
dards for food and water.”
According to Harvey Anderson, who
chairs ILSI’s Board of Trustees, the organiza-
tion has never taken part in such activities
anyway. While its strongest critics accuse
ILSI of working behind the scenes to pres-
ent information that would shape public
policy to corporate advantage, Anderson
points out that ILSI functions according to
a nonprofit charter bound by U.S. regula-
tions, with a board dominated by members
not affiliated with any vested interest, who
would readily vote down such lobbying.
“ILSI is overrun by lawyers making
damn sure everybody holds to the charter,”
he explains, noting that representatives like
himself—a nutritional sciences professor at
the University of Toronto—are unpaid
volunteers devoting a great deal of time and
energy to what they regard as a research
endeavour.
“ILSI has gathered some of the top sci-
entists from around the world to work with
industry and work with government and
work with their colleagues on issues that
need this kind of cooperative approach,”
says Anderson. “We publish our research
and reports in journals that require peer
review by their standards and by scientists of
their choice.”
Observers such as Jennifer Sass, a scien-
tist with the Natural Resources Defense
Council, insist that this approach neverthe-
less yields skewed science. Her group draft-
ed a letter of protest that was circulated by
hand at the Geneva meeting, citing exam-
ples of ILSI’s undue influence in shaping the
conclusions of scientific studies on issues
such as the role of sugar in diet and the des-
ignation of cancer-causing agents. 
“Their documents come out in one
direction, which is always somewhere
between ‘everything’s okay’ and ‘we need
more study,’” she says, referring to ILSI’s
participation in a 1998 study that denied
finding evidence of a direct link between
sugar intake and lifestyle-related diseases.
According to Sass, that conclusion conflicts
with the results from a 1990 WHO study
group, which recommended health policy
targets that reflect the increased risks of
chronic diseases caused by dietary patterns
that include high sugar intake. 
“They never come out as ‘this is a big
problem and we should do something about
it,’” says Sass, adding that governments can
perpetuate a misrepresentation of this
research by condoning ILSI’s approach. 
Similar complaints voiced in the 1990s
were followed by a 2001 report by the
WHO Tobacco-Free Initiative on how
member tobacco companies had used ILSI
to muster seemingly unbiased scientific
opinions aimed at quashing WHO tobacco
control efforts. ILSI vehemently denied
these allegations and, Anderson says, worked
with the WHO to provide assurances of
transparency about how ILSI operates. 
Derek Yach, now head of the Rockefeller
Foundation’s Program on Global Health,
led that WHO initiative and closely
watched ILSI’s response. “Part of the prob-
lem lies with the UN agencies themselves, or
in this case the WHO,” he concludes, not-
ing that these bodies have yet to take many
of the protective measures recommended by
the report. “You can blame the corpora-
tions,” he says, “but you also need to place
blame on not having very clear, very trans-
parent review of conflict-of-interest proce-
dures internally.” –Tim Lougheed
Tracking Toxicants in
Canadians
Health Canada announced in May 2006 that it
would begin a national biomonitoring program to
measure levels of toxic chemicals in the bodies of
Canadians. The announcement came as the NGO
Environmental Defense prepared to release the
results of its own
tests, the first look at
the amounts of
chemicals showing up
in Canadian adults and
children. That study
found 46 of 68
chemicals tested for,
with an average of 32
chemicals appearing in
adults and 23 in children. Compounds such as
polychlorinated biphenyls and DDT were found in
children born years after these chemicals were
banned. It is not yet known whether the new
program, set to begin in late 2007, will be
permanent.
Citizens Want Free Access to
Research Findings
The results of an online Harris poll released 1 June
2006 show that 82% of U.S. adults believe the
findings of federally funded research should be
available for free online, and that 62% believe free
access would lead to quicker discoveries that
positively impact health. Heather Joseph, executive
director of the Scholarly Publishing and Academic
Resources Coalition, commented, “The public
recognizes its stake in open sharing of resources,
and the Harris data gives voice to their stand.”
Senators John Cornyn (R–Texas) and Joseph
Lieberman (D–Connecticut) recently introduced the
Federal Research Public Access Act of 2006, which
would require federal agencies that fund over
$100 million in external research per year to make
their study results publicly available online.
Roadside Meth Risk
According to the National Advisory Council on Drug
Abuse, every pound of methamphetamine produced
means 5 to 7 pounds of toxic materials. Now
roadside cleanup volunteers and maintenance
workers are being
educated about the
dangers of picking up
litter tossed out when
meth labs clean house.
People coming across
such materials can
experience skin burns or
lung damage from
touching or inhaling
fumes from meth waste.
Several state and local
agencies have created
brochures and videos to
educate their workers.
Hints indicating a
roadside meth dump
site include bottles with rubber hoses attached, the
smell of ammonia, and coffee filters stained red or
containing a white powdery residue. 
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A Deadly MIF
Up to 2 million children die each
year from malaria, with about
half dying from malaria-induced
anemia. Scientists aren’t sure why
some malaria patients develop
this life-threatening complica-
tion and others don’t. A study
published in the 15 May 2006
Journal of Experimental Medicine
suggests the blame rests in part
on macrophage migration inhib-
itory factor (MIF), an immune
cytokine produced by white
blood cells.
The paper’s authors suspected
that MIF might suppress bone
marrow activity, because polymorphisms of the MIF gene increase
susceptibility to different inflammatory and infectious disorders.
“MIF appears to be part of an over-exuberant response on the part of
the immune system in a number of diseases, so it was a logical choice
for us to look at,” says coauthor Michael A. McDevitt, a hematolo-
gist at the Johns Hopkins University School of Medicine. The team
infected mice that were genetically modified to lack the Mif gene with
malaria parasites. About one-third of those mice survived, compared
to only 9% of the normal mice. 
MIF doesn’t act alone, the researchers discovered when they took
progenitor cells from the bone marrow of mice and allowed the cells
to grow both with and without MIF and two other immune factors,
TNFα and IFNγ. Applied alone in low concentrations, none of the
immune factors seriously damaged the bone marrow cells. “But when
we added all three together at the same low levels, we witnessed a syn-
ergistic poisoning of bone marrow,” says McDevitt. 
MIF probably prevents cells in the bone marrow from respond-
ing to erythropoietin, the hormone that triggers red blood cell
production, says coauthor Richard
Bucala, an immunologist and
rheumatologist at Yale University
School of Medicine. Some people’s
immune system may make too
much MIF in response to malarial
infection. About 30% of the popu-
lation in Africa, where malaria is
rampant, produces excessive MIF
protein, earlier studies have shown. 
MIF isn’t the only cause of
malarial anemia. The Plasmodium
parasite destroys red blood cells,
and the spleen also removes infect-
ed and even some uninfected cells.
“The pathogenesis of [malarial]
anemia has been a mystery for a
long time,” says Peter J. Hotez, a
parasitologist at George Washing-
ton University. “This mouse study
adds to the evidence . . . that MIF impedes the production of red
blood cells.” 
Understanding the mechanisms behind malarial anemia could
help direct future therapies. MIF is the key therapeutic target, because
blocking it alone protects the cells, whereas blocking TNFα or IFNγ
alone doesn’t, explains Bucala. Since the blood transfusions needed to
treat severe anemia are often difficult for many poor families to find
or afford, researchers hope to determine early on which children need
immediate care to prevent the anemia. 
To that end, Bucala and colleagues are collaborating on a project
with Macha Mission Hospital in Zambia to assess the frequency of
MIF polymorphisms in children with malarial anemia. They use a
new, inexpensive method to identify the polymorphism in just 2
hours, letting them know whether a child will likely need a transfu-
sion. In Zambia, children have a well-baby visit soon after birth, and
it is possible every baby could get genotyped, says Bucala, who adds,
“Then the mother would know that if her child develops fever in the
rainy season, she should go to the hospital quickly.” –Tina Adler
INFECTIOUS DISEASE
Ozone: Good, Bad,
or Indifferent?
Following up on their eye-catching finding
that the human body generates its own
ozone for beneficial purposes, a team of
U.S. and British researchers now describe
specific processes through which ozone can
react with cholesterol and contribute to
atherosclerosis, or hardening of the arteries.
Whether the ozone involved comes from
within the body or from the environment
remains unclear, however, and the team’s
findings remain controversial on several
counts. 
In earlier work, Paul Wentworth, Jr., a
chemistry professor at The Scripps Research
Institute, and colleagues concluded that self-
generated ozone is used by the immune sys-
tem’s antibodies and neutrophils to destroy
bacteria and fungi. They published a study
in 2003 showing that ozone can damage the
vascular system by contributing to athero-
sclerosis. They also noted the same process
may play a role in diseases such as lupus,
multiple sclerosis, and rheumatoid arthritis.
The mechanism by which such damage
occurs wasn’t clear in the 2003 study, how-
ever. Some of that information was filled in
with a report published 13 June 2006 in
Biochemistry. Through a series of in vitro
tests, the team exposed human and mouse
cells to two by-products of ozone’s interac-
tion with cholesterol, atheronal-A and
atheronal-B. They found that one, the other,
or both atheronals accelerate the normal
conversion of monocytes to macrophages,
are rapidly taken up by macrophages, has-
ten the inflammatory response on and
increase the stickiness of the interior arterial
walls, and contribute to the formation of
arterial plaques.
Numerous questions remain about the
research protocols (such as a lack of controls
to prove that ozone was the oxidant at
work) and conclusions regarding the body’s
self-generation of ozone (such as whether
cells are likely to expend so much energy to
produce their own ozone), says William
Pryor, director of the Biodynamics Institute
at Louisiana State University. Further, there
is little solid evidence that environmental
ozone plays a role in this specific process,
although exposure to atmospheric ozone
has been implicated in a number of cardio-
vascular problems, including heart attack
and changes in heart rhythm. 
Wentworth acknowledges that increased
cholesterol ingestion may be the most
important driving factor in the atheroscle-
rotic damage his team found—many of the
harmful atheronal processes occurred only
when “bad” LDL cholesterol was present.
Still, this line of inquiry may contribute to
better insights about the complex relation-
ships between the body’s normal functions,
reactive oxygen species including ozone, and
cardiovascular damage, leading even its crit-
ics to say this concept deserves attention,
analysis, and more research. –Bob Weinhold
ENVIRONMENTAL DISEASE
Unraveling a life-threatening complication. A genotyping project at
Macha Mission Hospital in Zambia, where director Phil Thuma (center) con-
ducts pediatric rounds, aims to prevent malaria-induced anemia in children.T
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Cairo Hails New Fleet
of Eco-Cabs 
Cairo is known for its poor air quality, with its
near-permanent haze a mix of industrial
emissions, desert sand, and car exhaust fumes. In
March 2006, a small fleet of new taxis hit the
streets of Egypt’s capital city. Unlike their
predecessors, the 150 new yellow Hyundais and
Volkswagens
feature catalytic
converters to filter
their exhaust, along
with air condition-
ing and seat belts.
A scheme laid out
by Egyptian prime
minister Ahmed
Nazif calls for a
total of 1,500 new
taxis to be available by the end of 2006. The
Christian Science Monitor reported on 1 June 2006
that the Egyptian government is also considering
fueling the vehicles with natural gas.
Living Low Poses Risk
Although only 2.2% of the world’s land area is less
than 10 meters above sea level, 10% of the
world’s population—some 600 million people—
lives at these low elevations. Of these, 60% live in
urban areas. A report in the April 2006 news
bulletin Tiempo by researchers from The Earth
Institute at Columbia University states these
people are at risk from rising sea levels and
increasingly strong storms due to climate change.
Geographical location isn’t the only factor that
determines vulnerability, however. Although the
United States has more urban areas in low-
elevation coastal zones than any other country,
low-income countries and those designated as
Least Developed Countries have fewer resources
to rebound from the effects of climate variability.
A Plan for Farm Plastics
Farmers use “ag plastics” for a wide variety of
purposes—dairy and silage bags, coverings for
crops, wrappings for hay bales, and more—and
thousands of tons are burned, buried, or dumped
annually. Now Cornell University researcher Lois
Levitan is developing a
pilot program to collect
and recycle used plastic
film sheeting from New
York dairies and nurseries. 
Levitan reports that
about half of discarded
ag plastic is burned, which
generates emissions of
dioxin and other hazard-
ous chemicals. Other
waste plastic is often
plowed into the ground,
where it can become a
breeding place for insect
pests as well as trap and
choke wildlife. Levitan
suggests recycling plastics into fence posts, plastic
lumber, garbage bags, and other uses, or
converting the plastic resin content to a fuel.
ehpnet
From huge industrial spills to exposure to everyday products,
there are a number of ways people come in contact with poten-
tially hazardous chemicals. To help educate those wanting more
in-depth information about the health effects of chemicals, the
Collaborative on Health and the Environment (CHE) has devel-
oped the CHE Toxicant and Disease Database, available online at
http://database.healthandenvironment.org/. 
The CHE was formed in 2002 as a project of the nonprofit
health and environmental research institute Commonweal with a
mission to foster a greater understanding of the links between
human health and the environment. The database, which summa-
rizes links between chemical contaminants and approximately 180
human diseases and conditions, has
been enhanced recently with new
search features and a directory of links
to other resources that would be of
interest to visitors to the CHE site. 
Background information on the
theory behind the database project is
available through a link in the text
paragraph near the top of the home-
page. Here, visitors can learn about the
nature of gene–environment interactions and their impacts on
human health; the lack of toxicity data on many of the 80,000-
plus chemicals that have been developed, distributed, and dis-
carded over the past 50 years; and the difficulties encountered in
assessing the risk of chemical exposures. This page also describes
where the information in the database came from, how chemicals
are categorized, and what limitations there are to the database. 
The homepage features an alphabetical listing of diseases and
conditions—ranging from abnormal sperm to Wilm’s tumor—that
can potentially be triggered by exposure to environmental chemi-
cals. Each disease or condition links to a page listing its chemically
related causes. These causes are grouped by the strength of evi-
dence—strong, good, or limited—of the relationship between the
health effect and the chemical. Each page also cites references.
Choosing one of the listed chemical causes brings up a record of all
of the diseases and conditions linked to that chemical.
The database can be searched using one of the pull-down lists
at the right of the homepage. There are options for searching by
any of 25 disease categories, by individual disease, or by any of
dozens of toxicants. Searches can also be performed by Chemical
Abstract Service number and by keyword. 
The directory available through the Links to Other Databases
and Resources link cites 17 databases, including ones hosted by
the NIEHS, the CDC, the EPA, the ATSDR, and the International
Agency for Research on Cancer. Other resources listed include the
CDC’s  National Report on Human Exposure to Environmental
Chemicals, the National Toxicology Program and its 11th Report
on Carcinogens, the California Office of Environmental Health
Hazard Assessment, and EHP. –Erin E. Dooley
Collaborative on Health 
and the Environment 
Toxicant and Disease Database